skip to content

Cambridge Cardiovascular



I am involved in clinical research in the field of Advanced Heart Failure, particularly with respect to the use of cardiac implantable electronic devices, mechanical circulatory support and heart transplantation. 


Key publications: 


  1. Socioeconomic deprivation and survival after heart transplantation in England: an analysis of the United Kingdom Transplant Registry Evans JDW, Kaptoge S, Caleyachetty R, Di Angelantonio E, Lewis C, Parameshwar KJ, Pettit SJ Circulation Cardiovasc Qual Outcomes 2016 (accepted for publication)

  2. Alemtuzumab as a novel treatment for refractory giant cell myocarditis after heart transplantation Evans JDW, Pettit SJ, Goddard M, Lewis C, Parameshwar KJ J Heart Lung Transplant 2016;35:256-258.  PMID:26508724

  3. Right heart catheterization may be cautiously performed through a mechanical valve prosthesis in the tricuspid position Pettit SJ, Tsui S, Parameshwar KJ BMJ Case Reports 2016  doi:10.1136/bcr-2016-215326  (published on-line).  PMID: 27074812

  4. The management of patients with aortic regurgitation and severe left ventricular dysfunction: a systematic review Badar AA, Brunton APT, Mahmood AH, Dobbin S, Pozzi A, McMinn JF, Sinclair AJE , Gardner RS, Petrie MC, Curry PA, Al-Attar NHK, Pettit SJ Expert Rev Cardiovasc Ther 2015; 13:915-922.  PMID: 26163051

  5. Heart Transplantation for Advanced Heart Failure due to Cardiac Sarcoidosis Theofilogiannakos EK, Pettit SJ, Ghazi A, Rassl D, Lewis C, Parameshwar J Sarcoidosis Vasc Diffuse Lung Dis 2015; 32:208-214.  PMID: 26422565

  6. Right ventricular failure due to late embolic RV infarction during continuous flow LVAD support Plymen C, Pettit SJ, Tsui SSL, Lewis C BMJ Case Reports 2015  doi: 10.1136/bcr-2015-212174  (published on-line).  PMID 26677152

  7. Percutaneous withdrawal of HeartWare HVAD left ventricular assist device support Pettit SJ, Shapiro LM, Lewis C, Parameshwar JK, Tsui SSL J Heart Lung Transplant 2015;34:990-992.  PMID 25843517

  8. Interventricular Lead Separation is Critical for NT-Pro BNP Reduction after Cardiac Resynchronisation Therapy Lang NN, Badar A, Pettit SJ, Templeton S, Connelly DT, Gardner RS Biomark Med 2014; 8:797-806.  PMID: 25224936

  9. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable-cardioverter-defibrillator implantation? Randles DA, Hawkins NM, Shaw M, Patwala AY, Pettit SJ, Wright DJ Europace 2014; 16:1015-1021.  PMID: 24351884

  10. Clinical experience of subcutaneous and transvenous implantable cardioverter-defibrillators in children and teenagers Pettit SJ, McLean A, Colquhoun I, Connelly D, McLeod K Pacing Clin Electophysiol 2013; 36:1532-1538.  PMID: 24033753

  11. Deactivation of implantable cardioverter-defibrillators at end of life Pettit SJ, Jackson CE, Gardner RS Future Cardiology 2013; 9:885-896.  PMID: 24180544

  12. How small is too small?  A systematic review of centre volume and outcome after cardiac transplantation Pettit SJ, Jhund PS, Hawkins NM, Gardner RS, Haj-Yahia S, McMurray JJV, Petrie MC Circulation Cardiovasc Qual Outcomes 2012;5:783-790.  PMID: 23132331

  13. Use of implantable cardioverter defibrillators in patients with left ventricular assist devices Pettit SJ, Petrie MC, Connelly DT, Japp AG, Payne JR, Haj Yahia S, Gardner RS Eur J Heart Fail 2012; 14:696-702.  PMID: 22547745


Consultant Cardiologist
Dr Stephen  Pettit

Contact Details


Person keywords: 
Natriuretic peptides
heart failure
Heart Transplantation
Left Ventricular Assist Devices